Post-traumatic OA (PTOA): what have we learned to advance osteoarthritis?

Purpose of review: Current thinking in the study of post-traumatic osteoarthritis (PTOA) is overviewed: the osteoarthritis which follows acute joint injury. The review particularly highlights important publications in the last 18 months, also...

Descrición completa

Detalles Bibliográficos
Autor Principal:	Watt, F
Formato:	Journal article
Idioma:	English
Publicado:	Wolters Kluwer 2020

Títulos similares

Mechanical loading and orthobiologic therapies in the treatment of post-traumatic osteoarthritis (PTOA): a comprehensive review
por: Mahammad Gardashli, et al.
Publicado: (2024-06-01)

Correlation of damage score in PTOA with changes in stress on cartilage in an ovine model
por: Paris Vakiel, et al.
Publicado: (2020-12-01)

Enhancing autophagy and energy metabolism in the meniscus can delay the occurrence of PTOA in ACLT rat
por: Huangrong Zhu, et al.
Publicado: (2022-09-01)

Fibromodulin and tenascin N are potential biomarkers of post-traumatic OA
por: Papadopoulou, A, et al.
Publicado: (2014)

What have we learned?
por: Peter Rodgers, et al.
Publicado: (2021-12-01)

A Decade of Imaging Patients with Traumatic Brachial Plexopathy: What have We Learned?
por: Vaishali Upadhyaya, et al.
Publicado: (2023-01-01)

Chernobyl and Fukushima nuclear accidents: What have we learned and what have we done?
por: Đurović Branka, et al.
Publicado: (2016-01-01)

Cellular and Molecular Pathophysiology of Traumatic Brain Injury: What Have We Learned So Far?
por: Marco Aurelio M. Freire, et al.
Publicado: (2023-08-01)

GOAL: What Have We Learned?
por: Leek Timothy
Publicado: (2005-09-01)

Early knee OA definition–what do we know at this stage? An imaging perspective
por: Xiaojuan Li, et al.
Publicado: (2023-03-01)

Orthopaedic infections: what have we learned?
por: Christopher Lee, MD, et al.
Publicado: (2023-05-01)

Development Economics: What Have We Learned?
por: Jagdish N. Bhagwati
Publicado: (1984-01-01)

Phage Therapy: What Have We Learned?
por: Andrzej Górski, et al.
Publicado: (2018-05-01)

What have we learned from the pandemic?
por: Iêda Maria Barbosa Aleluia
Publicado: (2021-03-01)

COVID-19: what have we learned?
por: Yeh-Li Ho, et al.
Publicado: (2020-06-01)

What have we learned? : ten years on /
por: Ashkanasy, Neal M., 1945-, et al.
Publicado: (2011)

PTH Assays: Understanding What We Have and Forecasting What We Will Have
por: Jose Gilberto H. Vieira
Publicado: (2012-01-01)

A modeling dialog with AI – what do we learn about what we have to learn?
por: Joolingen, Wouter van
Publicado: (2024)

What we have learned from the Myriad trials.
por: Hendrix, S, et al.
Publicado: (2009)

What Have We Not Learned from the Convergence Debate?
por: Leone Leonida
Publicado: (2023-04-01)

Fifty Years of the Hypotelminorheic: What Have We Learned?
por: Tanja Pipan, et al.
Publicado: (2012-12-01)

The COVID-19 challenge. What have we learned?
por: Adrian Ceccato, et al.
Publicado: (2022-11-01)

What we have learned from the Rigopiano tragedy
por: Antonella Pescini, et al.
Publicado: (2019-12-01)

The pilocarpine model of epilepsy: what have we learned?
por: Fulvio A. Scorza, et al.
Publicado: (2009-09-01)

The infrared Galactic disk: What have we learned?
por: Churchwell E.
Publicado: (2012-02-01)

Lymphopenia in Esophageal Cancer: What Have We Learned?
por: Jia-Lin Wang, et al.
Publicado: (2021-03-01)

The economics of agricultural development: what have we learned?
por: Roumasset James
Publicado: (2006-07-01)

COVID-19 pandemic – What have we learned?
por: Manjunath Premanath
Publicado: (2021-01-01)

Development and democracy : what have we learned and how? /
por: Hyden, Goran, et al.
Publicado: (2002)

COVID-19 pandemic. What have we learned?
por: Cristina Calvo, et al.
Publicado: (2021-11-01)

Factors determining the development of post-traumatic pain and post-traumatic osteoarthritis
por: A. A. Chernikova, et al.
Publicado: (2023-06-01)

Five decades of Fontan palliation: What have we learned? What should we expect?
por: Adil Hassan, et al.
Publicado: (2023-10-01)

Tegumentary leishmaniasis in the State of Amazonas: what have we learned and what do we need?
por: Jorge Augusto de Oliveira Guerra, et al.
Publicado: (2015-06-01)

ASICs in PET: what we have and what we need
por: Vanessa Nadig, et al.
Publicado: (2025-02-01)

Nonalcoholic fatty liver disease: What do we know and what will we have to learn?
por: N I Volkova, et al.
Publicado: (2017-02-01)

Telemedicine in Heart Failure in the COVID-19 and Post-Pandemic Era: What Have We Learned?
por: Mateusz Sokolski, et al.
Publicado: (2023-08-01)

Lipoabdominoplasty: What We Have Implemented and What We Have Modified over 26 Years
por: Lázaro Cárdenas-Camarena, MD, et al.
Publicado: (2023-02-01)

What We Have Learned and What We Have Missed in Tuberculosis Pathophysiology for a New Vaccine Design: Searching for the “Pink Swan”
por: Pere-Joan Cardona
Publicado: (2017-05-01)

The Gonadotropin-Inhibitory Hormone: What We Know and What We Still Have to Learn From Fish
por: María P. Di Yorio, et al.
Publicado: (2019-02-01)

What we have learned and what the future holds: Perspectives on the COVID-19
por: Adrián Camacho-Ortiz
Publicado: (2021-10-01)